About
Small molecules for bacterial infections
Areas of Focus
Categories
Small Molecule PharmaceuticalMountain West
Team (12)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
12,414
By Phase
PHASE1: 1PHASE2: 1NA: 2
By Status
COMPLETED: 3UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06988423Lead Sponsor
Evaluation of the Potential Impact of a High-fat Meal on the Pharmacokinetics of CRS3123 in Healthy Adult Participants
PHASE1Completed
17 participants
Started: May 9, 2025 · Completed: Jun 4, 2025
NCT04781387Lead Sponsor
Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection
PHASE2Completed
43 participants
Started: Jan 5, 2021 · Completed: Apr 16, 2024
NCT03705208Lead Sponsor
Youth First: A Longitudinal Impact Evaluation
NAUnknown
7,762 participants
Started: May 8, 2018 · Completed: Dec 31, 2021
NCT02429661Lead Sponsor
Girls First - India (2013-2015)
NACompleted
4,592 participants
Started: May 31, 2013 · Completed: Mar 31, 2015
Funding History (1)
D
Sep 21, 2021
Locations (1)
Headquarters
Boulder, CO, United States
Map
Loading map...